Cancer Tumor Profiling Market Report

Global and Region Cancer Tumor Profiling Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：225
  • REPORT CODE：GMM920992
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cancer Tumor Profiling market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Tumor Profilingmarket, defines the market attractiveness level of Cancer Tumor Profiling market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Tumor Profiling industry, describes the types of Cancer Tumor Profiling market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Tumor Profiling market and the development prospects and opportunities of Cancer Tumor Profiling industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Tumor Profiling market in Chapter 13.

    By Player:

    • Perthera Inc

    • Personal Genome Diagnostics Inc

    • Agendia

    • Illumina Inc

    • GenScript

    • V, Strand

    • Roche Molecular Systems Inc

    • Hologic Gen-Probe

    • HTG Molecular Diagnostic

    • Abott Molecular

    • Siemens Healthineers

    • ApoCell

    • Genomic Health Inc

    • Foundation Medicine Inc

    • BD Biosciences

    • Claris Life Sciences

    • NeoGenomics Laboratories

    • Contextual Genomics

    • Qiagen NV

    By Type:

    • Next-generation Sequencing (NGS)

    • Polymerase Chain Reaction (PCR)

    • Immunohistochemistry (IHC)

    • In Situ Hybridization (ISH)

    • Microarray

    • Others

    By End-User:

    • Personalized Medicine

    • Diagnostics

    • Biomarker Discovery

    • Prognostics

    • Research Applications

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Tumor Profiling Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Tumor Profiling Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Tumor Profiling Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Tumor Profiling Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Tumor Profiling Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Tumor Profiling Consumption (2017-2022)

    • 7.2 United States Cancer Tumor Profiling Consumption (2017-2022)

    • 7.3 Europe Cancer Tumor Profiling Consumption (2017-2022)

    • 7.4 China Cancer Tumor Profiling Consumption (2017-2022)

    • 7.5 Japan Cancer Tumor Profiling Consumption (2017-2022)

    • 7.6 India Cancer Tumor Profiling Consumption (2017-2022)

    • 7.7 South Korea Cancer Tumor Profiling Consumption (2017-2022)

    8 Region and Country-wise Cancer Tumor Profiling Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Tumor Profiling Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Tumor Profiling Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Tumor Profiling Consumption Forecast (2022-2028)

    • 8.4 China Cancer Tumor Profiling Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Tumor Profiling Consumption Forecast (2022-2028)

    • 8.6 India Cancer Tumor Profiling Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Tumor Profiling Consumption Forecast (2022-2028)

    9 Global Cancer Tumor Profiling Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Tumor Profiling Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Next-generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Polymerase Chain Reaction (PCR) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunohistochemistry (IHC) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global In Situ Hybridization (ISH) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Microarray Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Tumor Profiling Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Personalized Medicine Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Biomarker Discovery Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prognostics Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Research Applications Consumption and Growth Rate (2017-2022)

    10 Global Cancer Tumor Profiling Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Tumor Profiling Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Next-generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Polymerase Chain Reaction (PCR) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunohistochemistry (IHC) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global In Situ Hybridization (ISH) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Microarray Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Tumor Profiling Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Biomarker Discovery Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prognostics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Research Applications Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Tumor Profiling Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Tumor Profiling Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Tumor Profiling Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Tumor Profiling Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Tumor Profiling Market Competitive Analysis

    • 14.1 Perthera Inc

      • 14.1.1 Perthera Inc Company Details

      • 14.1.2 Perthera Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Perthera Inc Cancer Tumor Profiling Product and Service

    • 14.2 Personal Genome Diagnostics Inc

      • 14.2.1 Personal Genome Diagnostics Inc Company Details

      • 14.2.2 Personal Genome Diagnostics Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Personal Genome Diagnostics Inc Cancer Tumor Profiling Product and Service

    • 14.3 Agendia

      • 14.3.1 Agendia Company Details

      • 14.3.2 Agendia Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Agendia Cancer Tumor Profiling Product and Service

    • 14.4 Illumina Inc

      • 14.4.1 Illumina Inc Company Details

      • 14.4.2 Illumina Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Illumina Inc Cancer Tumor Profiling Product and Service

    • 14.5 GenScript

      • 14.5.1 GenScript Company Details

      • 14.5.2 GenScript Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GenScript Cancer Tumor Profiling Product and Service

    • 14.6 V, Strand

      • 14.6.1 V, Strand Company Details

      • 14.6.2 V, Strand Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 V, Strand Cancer Tumor Profiling Product and Service

    • 14.7 Roche Molecular Systems Inc

      • 14.7.1 Roche Molecular Systems Inc Company Details

      • 14.7.2 Roche Molecular Systems Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Roche Molecular Systems Inc Cancer Tumor Profiling Product and Service

    • 14.8 Hologic Gen-Probe

      • 14.8.1 Hologic Gen-Probe Company Details

      • 14.8.2 Hologic Gen-Probe Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Hologic Gen-Probe Cancer Tumor Profiling Product and Service

    • 14.9 HTG Molecular Diagnostic

      • 14.9.1 HTG Molecular Diagnostic Company Details

      • 14.9.2 HTG Molecular Diagnostic Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 HTG Molecular Diagnostic Cancer Tumor Profiling Product and Service

    • 14.10 Abott Molecular

      • 14.10.1 Abott Molecular Company Details

      • 14.10.2 Abott Molecular Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abott Molecular Cancer Tumor Profiling Product and Service

    • 14.11 Siemens Healthineers

      • 14.11.1 Siemens Healthineers Company Details

      • 14.11.2 Siemens Healthineers Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Siemens Healthineers Cancer Tumor Profiling Product and Service

    • 14.12 ApoCell

      • 14.12.1 ApoCell Company Details

      • 14.12.2 ApoCell Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 ApoCell Cancer Tumor Profiling Product and Service

    • 14.13 Genomic Health Inc

      • 14.13.1 Genomic Health Inc Company Details

      • 14.13.2 Genomic Health Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Genomic Health Inc Cancer Tumor Profiling Product and Service

    • 14.14 Foundation Medicine Inc

      • 14.14.1 Foundation Medicine Inc Company Details

      • 14.14.2 Foundation Medicine Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Foundation Medicine Inc Cancer Tumor Profiling Product and Service

    • 14.15 BD Biosciences

      • 14.15.1 BD Biosciences Company Details

      • 14.15.2 BD Biosciences Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 BD Biosciences Cancer Tumor Profiling Product and Service

    • 14.16 Claris Life Sciences

      • 14.16.1 Claris Life Sciences Company Details

      • 14.16.2 Claris Life Sciences Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Claris Life Sciences Cancer Tumor Profiling Product and Service

    • 14.17 NeoGenomics Laboratories

      • 14.17.1 NeoGenomics Laboratories Company Details

      • 14.17.2 NeoGenomics Laboratories Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 NeoGenomics Laboratories Cancer Tumor Profiling Product and Service

    • 14.18 Contextual Genomics

      • 14.18.1 Contextual Genomics Company Details

      • 14.18.2 Contextual Genomics Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Contextual Genomics Cancer Tumor Profiling Product and Service

    • 14.19 Qiagen NV

      • 14.19.1 Qiagen NV Company Details

      • 14.19.2 Qiagen NV Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Qiagen NV Cancer Tumor Profiling Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Tumor Profiling

    • Figure Cancer Tumor Profiling Picture

    • Table Global Cancer Tumor Profiling Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Tumor Profiling Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Tumor Profiling Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Tumor Profiling Consumption by Country (2017-2022)

    • Figure United States Cancer Tumor Profiling Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Tumor Profiling Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Tumor Profiling Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Tumor Profiling Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Tumor Profiling Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Tumor Profiling Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Tumor Profiling Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Tumor Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Tumor Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Tumor Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Tumor Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Tumor Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Tumor Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Next-generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Figure Global Polymerase Chain Reaction (PCR) Consumption and Growth Rate (2017-2022)

    • Figure Global Immunohistochemistry (IHC) Consumption and Growth Rate (2017-2022)

    • Figure Global In Situ Hybridization (ISH) Consumption and Growth Rate (2017-2022)

    • Figure Global Microarray Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Personalized Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Biomarker Discovery Consumption and Growth Rate (2017-2022)

    • Figure Global Prognostics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Applications Consumption and Growth Rate (2017-2022)

    • Figure Global Next-generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polymerase Chain Reaction (PCR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunohistochemistry (IHC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global In Situ Hybridization (ISH) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microarray Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biomarker Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prognostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Applications Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Tumor Profiling Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Tumor Profiling Export by Region (Top 5 Countries) (2017-2028)

    • Table Perthera Inc (Foundation Year, Company Profile and etc.)

    • Table Perthera Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perthera Inc Cancer Tumor Profiling Product and Service

    • Table Personal Genome Diagnostics Inc (Foundation Year, Company Profile and etc.)

    • Table Personal Genome Diagnostics Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Personal Genome Diagnostics Inc Cancer Tumor Profiling Product and Service

    • Table Agendia (Foundation Year, Company Profile and etc.)

    • Table Agendia Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agendia Cancer Tumor Profiling Product and Service

    • Table Illumina Inc (Foundation Year, Company Profile and etc.)

    • Table Illumina Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Inc Cancer Tumor Profiling Product and Service

    • Table GenScript (Foundation Year, Company Profile and etc.)

    • Table GenScript Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table GenScript Cancer Tumor Profiling Product and Service

    • Table V, Strand (Foundation Year, Company Profile and etc.)

    • Table V, Strand Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table V, Strand Cancer Tumor Profiling Product and Service

    • Table Roche Molecular Systems Inc (Foundation Year, Company Profile and etc.)

    • Table Roche Molecular Systems Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Molecular Systems Inc Cancer Tumor Profiling Product and Service

    • Table Hologic Gen-Probe (Foundation Year, Company Profile and etc.)

    • Table Hologic Gen-Probe Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Gen-Probe Cancer Tumor Profiling Product and Service

    • Table HTG Molecular Diagnostic (Foundation Year, Company Profile and etc.)

    • Table HTG Molecular Diagnostic Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table HTG Molecular Diagnostic Cancer Tumor Profiling Product and Service

    • Table Abott Molecular (Foundation Year, Company Profile and etc.)

    • Table Abott Molecular Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abott Molecular Cancer Tumor Profiling Product and Service

    • Table Siemens Healthineers (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthineers Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers Cancer Tumor Profiling Product and Service

    • Table ApoCell (Foundation Year, Company Profile and etc.)

    • Table ApoCell Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table ApoCell Cancer Tumor Profiling Product and Service

    • Table Genomic Health Inc (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Inc Cancer Tumor Profiling Product and Service

    • Table Foundation Medicine Inc (Foundation Year, Company Profile and etc.)

    • Table Foundation Medicine Inc Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foundation Medicine Inc Cancer Tumor Profiling Product and Service

    • Table BD Biosciences (Foundation Year, Company Profile and etc.)

    • Table BD Biosciences Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Biosciences Cancer Tumor Profiling Product and Service

    • Table Claris Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Claris Life Sciences Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Claris Life Sciences Cancer Tumor Profiling Product and Service

    • Table NeoGenomics Laboratories (Foundation Year, Company Profile and etc.)

    • Table NeoGenomics Laboratories Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeoGenomics Laboratories Cancer Tumor Profiling Product and Service

    • Table Contextual Genomics (Foundation Year, Company Profile and etc.)

    • Table Contextual Genomics Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Contextual Genomics Cancer Tumor Profiling Product and Service

    • Table Qiagen NV (Foundation Year, Company Profile and etc.)

    • Table Qiagen NV Cancer Tumor Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen NV Cancer Tumor Profiling Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US